CAAS Capital Management’s Immuneering IMRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-40,000	Closed	-$1.06M	–	562
2021 Q3	$1.06M	Buy	+40,000	New	+$1.06M	0.02%	212